SHARE
COPY LINK

SAAB

GM set to pump billions into Saab deal

General Motors is set to pay out an estimated 10 billion kronor ($1.4 billion) in a bid to ensure it completes the sale of its troubled Swedish subsidiary.

But the American car maker has also indicated it intends to retain ties to Saab Automobile even after the Swedish unit has been sold to the Koenigsegg Group consortium.

“GM is going to have a certain interest in Saab as part of a special financial arrangement that will be revealed in due course,” said GM’s European manger Carl-Peter Forster, speaking to news agency TT at the Frankfurt Motor Show on Tuesday.

Koenigsegg Group representatives have previously stated that GM is prepared to shell out 2.8 billion kronor for preferential shares in Saab Automobile, a move that would enable the ailing US giant to benefit from any future Saab profits.

GM’s decision to sell Saab has already proved costly, with 7 billion kronor disappearing when the parent company took over a number of Saab’s debts to its subcontractors.

GM has also agreed to pay for the production tools for the new Saab 9-5 and to release the Swedish firm from commitments to repay a restructuring loan, undertakings that amount to a combined total of around 3 billion kronor.

GM has also said it will contribute to further alleviating Saab’s general cost burden to help ensure the successful implementation of Saab’s new business plan.

Saab chief Jan Åke Jonsson confirmed that GM’s contribution to Saab would land in the region of 10 billion kronor.

Jonsson added however that GM was hoping its goodwill would eventually lead to a return on its investment.

“We are going to retain our cooperation with GM through a number of agreements, and GM will deliver quite a few products to us that they make money from, such as engines and gearboxes,” he said.

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.

MONSANTO

Bayer buys Monsanto for $66 bn after months-long pursuit

German chemicals giant Bayer said on Wednesday it had signed a $66 billion (€58.8 billion) takeover deal with US seeds and pesticides firm Monsanto.

Bayer buys Monsanto for $66 bn after months-long pursuit
Photo: DPA

“Bayer and Monsanto today announced that they signed a definitive merger agreement under which Bayer will acquire Monsanto for USD 128 per share in an all-cash transaction,” the firms said in a statement.

Bayer repeatedly increased its offer to Monsanto since its first $122-per-share bid, but the US firm had until now held out for more cash.

“This represents a major step forward for our crop science business,” Bayer chief executive Werner Baumann said in the statement.

The two firms said that the deal “brings together two different, but highly complementary” businesses.

Monsanto shareholders still have to approve the deal, as do regulators – with Bayer staking a $2 billion reverse antitrust break fee in case the merger is rejected by US or European authorities.

The deal is expected to be completed by the end of 2017.

Bayer has been pursuing Monsanto since late May, when it made an initial bid of $122 per share (€109), valuing the US genetically modified (GM) crop giant at $62 billion. Monsanto rejected that bid, but said it was “open” to further talks.

Since then the German chemicals behemoth has raised its offer twice, first to $125 per share in July and then to $127.50 last week, but was rebuffed each time.

Mosanto held out for more money, calling the July bid “insufficient”.

The long-mooted tie-up has rung alarms bells for some farmers who fear the power of the combined company in the market for seeds and pesticides, while opponents of genetically-modified food in Europe worry about Monsanto's influence on the continent.

“We do not like this transaction, because we think that Bayer is overpaying significantly,” wrote analyst Peter Spengler of DZ bank on Wednesday before the deal was confirmed.

Monsanto's genetically modified (GM) seed offerings and Climate Corp data analytics offering to farmers would fit in with Bayer's crop protection lines, the firms said in the statement announcing the deal.

The combined group will also emerge with a total research and development budget of €2.5 billion. Added together, Bayer and Monsanto booked sales of €23 billion in 2015.

Bayer said that it expects synergy savings from the merger will allow it to add $1.5 billion to its underlying profit as measured by EBITDA within three years.

SHOW COMMENTS